Corporate Presentation Vaxart Investor Presentation November 2023 Past Presentations Cantor Healthcare Conference September 2023 Vaxart Monovalent Norovirus Challenge Study Data Review Vaxart Norovirus KOL Presentation Oral Tablet Vaccination to SARS-CoV-2 Induces Long Lasting Crossreactive Mucosal Antibody Responses in Humans – World Vaccine Congress 2022, Dr. Sean Tucker Potent Immune Responses to Norovirus G1.1 Evaluated in Elderly Subjects following Oral Tablet Delivery in a Phase 1 Placebo-Controlled Study – World Vaccine Congress 2022, Dr. James Cummings Mucosal rAd5 Immunization Against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in Non-Human Primates, Dr. Becca Flitter Americans tell pollsters they want an oral vaccine Oral Tablet Vaccination to SARS-CoV-2 Induces Pan-coronavirus Nasal IgA Responses in Humans, Dr. Sean Tucker The Importance of T-cell Responses for COVID-19 Vaccines, Dr. Sean Tucker
Oral Tablet Vaccination to SARS-CoV-2 Induces Long Lasting Crossreactive Mucosal Antibody Responses in Humans – World Vaccine Congress 2022, Dr. Sean Tucker
Potent Immune Responses to Norovirus G1.1 Evaluated in Elderly Subjects following Oral Tablet Delivery in a Phase 1 Placebo-Controlled Study – World Vaccine Congress 2022, Dr. James Cummings
Mucosal rAd5 Immunization Against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in Non-Human Primates, Dr. Becca Flitter
Oral Tablet Vaccination to SARS-CoV-2 Induces Pan-coronavirus Nasal IgA Responses in Humans, Dr. Sean Tucker
